Harvard Bioscience Inc. (HBIO) PT Lowered to $2 at Benchmark as Healthcare Faces 'Tough Year'

September 10, 2025 7:14 AM EDT Send to a Friend
(Updated - September 10, 2025 8:56 AM EDT)

Benchmark analyst Bruce Jackson lowered the price target on Harvard Bioscience ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login